A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MS / Member States

[Related PubMed/MEDLINE]
Total Number of Papers: 69
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MS  (>> Co-occurring Abbreviation)
Long Form:   Member States
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A comparison of the EU and US regulatory frameworks for the active substance registration of microbial biological control agents. EU, MBCA
2019 Ethical assessment of the EU health policy under the Directive 2011∕24∕EU: approaching patients' rights and cross-border healthcare. CBHC, EC, ERNs, EU, HTA
2019 How to manage accidental and unintended exposure in radiology: an ESR white paper. ---
2019 Is the European Health Interview Survey online yet? Response and net sample composition of a web-based data collection. EHIS
2019 Non-indigenous species refined national baseline inventories: A synthesis in the context of the European Union's Marine Strategy Framework Directive. MSFD, NIS
2019 Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting. ECDC, EU/EEA, PR, PRT
2019 Performance of the MARS-crop yield forecasting system for the European Union: Assessing accuracy, in-season, and year-to-year improvements from 1993 to 2015. EOC, EU, MCYFS
2018 Characteristics and correlates of electronic cigarette product attributes and undesirable events during e-cigarette use in six countries of the EUREST-PLUS ITC Europe Surveys. EU, TPD
2018 Comparison of official food safety control systems in member states of the European Union. CA, EU
10  2018 Composition and chemical health hazards of the most common electronic cigarette liquids in nine European countries. EU, GHS, TPD
11  2018 Electricity carbon intensity in European Member States: Impacts on GHG emissions of electric vehicles. CI, EVs, WTW
12  2018 European Core Health Indicators - status and perspectives. ECHI, EFTA, EU, OECD, WHO
13  2018 How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. WHO
14  2018 Key Messages for a Frailty Prevention and Management Policy in Europe from the ADVANTAGE JOINT ACTION Consortium. EC, EU, JA
15  2018 Knowledge of the health risks of smoking and impact of cigarette warning labels among tobacco users in six European countries: Findings from the EUREST-PLUS ITC Europe Surveys. EU, KHR, LII, TPD
16  2018 Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016). EAP, EU/EEA, WHO
17  2018 Patterns of tobacco use, quit attempts, readiness to quit and self-efficacy among smokers with anxiety or depression: Findings among six countries of the EUREST-PLUS ITC Europe Surveys. EU, PAD
18  2018 Prevalence and correlates of different smoking bans in homes and cars among smokers in six countries of the EUREST-PLUS ITC Europe Surveys. CI, EU, PR
19  2018 Secondhand exposure to e-cigarette aerosols among smokers: A cross-sectional study in six European countries of the EUREST-PLUS ITC Europe Surveys. e-cigarette, EU, SHA
20  2018 The Transition of EU Water Policy Towards the Water Framework Directive's Integrated River Basin Management Paradigm. EU, IRBM, WFD
21  2018 Understanding the implications of the EU-LULUCF regulation for the wood supply from EU forests to the EU. FRL, MFL
22  2017 Associations between national viral hepatitis policies/programmes and country-level socioeconomic factors: a sub-analysis of data from the 2013 WHO viral hepatitis policy report. HDI
23  2017 Key drivers for market penetration of biosimilars in Europe. EU
24  2017 The European Union Joint Procurement Agreement for cross-border health threats: what is the potential for this new mechanism of health system collaboration? EU, JPA
25  2016 A Transport and Lairage Model for Salmonella Transmission Between Pigs Applicable to EU Member States. ---
26  2016 Characterization of the Human Risk of Salmonellosis Related to Consumption of Pork Products in Different E.U. Countries Based on a QMRA. QMRA
27  2016 EU Failing FAO Challenge to Improve Global Food Security. EU, FAO, GM
28  2016 European Patient Summary Guideline: Focus on Greece. EU, PS
29  2016 Headcount and FTE data in the European health workforce monitoring and planning process. FTE, HWF
30  2016 Interoperability Architecture for a Paediatric Oncology European Reference Network. ERN, EU, ExPO-r-Net
31  2016 Relation between national-level tobacco control policies and individual-level voluntary home smoking bans in Europe. EU, PPACTE, TCS
32  2015 Overview of external reference pricing systems in Europe. ERP, EU
33  2015 Radionuclide monitoring in foodstuff: overview of the current implementation in the EU countries. EU
34  2015 The future of immunization policies in Italy and in the European Union: The Declaration of Erice. EPSCO
35  2015 [European Union Network for Patient Safety and Quality of Care (PASQ). Development and preliminary results in Europe and in the Spanish National Health System]. EU, GP, PASQ, PS, SCP, SNHS
36  2014 Haemoglobinopathies in Europe: health & migration policy perspectives. ENERCA, MH, RD, SCD, Thal, TIF
37  2014 Measuring performance in off-patent drug markets: a methodological framework and empirical evidence from twelve EU Member States. ---
38  2014 Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods. BCoDE, EFTA, MFs, UE
39  2014 Regulation of advanced therapy medicinal products in Europe and the role of academia. ATMP, EC, GMP
40  2014 Supporting health systems in Europe: added value of EU actions? EU's
41  2013 Good Environmental Status of marine ecosystems: what is it and how do we know when we have attained it? GEnS, MSFD
42  2013 Haematopoietic stem cell transplantation: a comparison between the accreditation process performed by competent authorities and JACIE in Italy. HSC
43  2013 Relative efficacy and effectiveness assessment of new pharmaceuticals in three EU member states: current practices and outcome agreement between Belgium, the Netherlands and France. ATV, EU, REA
44  2013 Stochastic spatio-temporal modelling of African swine fever spread in the European Union during the high risk period. ASF, EU, HRP
45  2013 Strengthening radiopharmacy practice in IAEA Member States. GMP, IAEA
46  2013 The joint action MODE (Mutual Organ Donation and Transplantation Exchanges): a sound contribution to implementation of health policies in organ donation and transplantation. EU
47  2013 The joint action on healthy life years (JA: EHLEIS). EU, HLY, SMPH
48  2013 The Procrustean bed of EU food safety notifications via the Rapid Alert System for Food and Feed: does one size fit all? RASFF
49  2012 Costs and benefits of freedom from shrimp diseases in the European Union. IRA, OIE, TSV, YHD
50  2012 Tuberculosis surveillance and control in Germany - An application of the Berlin Declaration Monitoring and Evaluation Framework. TB
51  2011 Surveillance and control of communicable diseases related to passenger ships in Europe. MDH, SHIPSAN
52  2011 Towards a standardised surveillance for Trichinella in the European Union. EU
53  2010 Data model for the collaboration between land administration systems and agricultural land parcel identification systems. CAP, EU, IACS, LAS, LPIS
54  2010 Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. EU, HCW, VENICE
55  2010 Hygiene inspections on passenger ships in Europe - an overview. EU
56  2010 Low-pathogenic notifiable avian influenza serosurveillance and the risk of infection in poultry - a critical review of the European Union active surveillance programme (2005-2007). DP, EU, LPNAI, PTs, RR
57  2010 Surveillance for avian influenza in wild birds in the European Union in 2007. EU, HPAI, LPAI
58  2009 European union and Spanish regulations on quality and safety of tissues and cells: overview and biovigilance. EU
59  2009 Needs and obstacles of uniform immunisation schedules in the European Union. EU
60  2009 Vaccine adverse event monitoring systems across the European Union countries: time for unifying efforts. AEFI, VENICE
61  2008 First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States. EU/EEA, IVE
62  2008 Impact of human interventions on the spread of bluetongue virus serotype 8 during the 2006 epidemic in north-western Europe. AFI, BTV, EU, TRACES
63  2008 Possible routes of introduction of bluetongue virus serotype 8 into the epicentre of the 2006 epidemic in north-western Europe. AFI, BT, BTV, HRP, TRACES
64  2007 Tackling rare diseases at European level: why do we need a harmonized framework? RD
65  2004 Mediterranean countries impact on the implementation of Council Directive 91/414/EEC. ---
66  2002 Brucellosis in the European Union and Norway at the turn of the twenty-first century. EU
67  2000 Bound residues of organic compounds in the soil: the significance of pesticide persistence in soil and water: a European regulatory view. a.s, EU
68  2000 Licensing new antibacterial agents - a European perspective. CPMP, EMEA, RMS, SPC
69  1998 Radiation protection legislation. BSS, MED